CoChat

Patient-reported outcomes in cancer care — hearing the patient voice at greater volume

LeBlanc, Thomas W., Abernethy, Amy P. · 2017 · Nature Reviews Clinical Oncology
Cited by 243

The DOI matches its Crossref record; 25 of the 25 references it cites were found in a registry or an index.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/nrclinonc.2017.153

Cites

25 of 25 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 25 references

Research works printed but not linked: 72

  1. Howie, L., Hirsch, B., Locklear, T. & Abernethy, A. P. Assessing the value of patient-generated data to comparative effectiveness research. Health Aff. 33, 1220–1228 (2014). · DOI
  2. Locklear, T. et al. Reaching consensus on patient-centered definitions: a report from the Patient-Reported Outcomes PCORnet Task Force. NIH Collaboratory https://www.nihcollaboratory.org/Products/Reaching%20Consensus_April_9_2015.pdf (2015).
  3. Basch, E. et al. Adverse symptom event reporting by patients versus clinicians: relationships with clinical outcomes. J. Natl Cancer Inst. 101, 1624–1632 (2009). · DOI · Paper page
  4. Atkinson, T. M. et al. Reliability of adverse symptom event reporting by clinicians. Qual. Life Res. 21, 1159–1164 (2012). · DOI · Paper page
  5. Mesa, R. A. et al. Effect of ruxolitinib therapy on myelofibrosis-related symptoms and other patient-reported outcomes in COMFORT-I: a randomized, double-blind, placebo-controlled trial. J. Clin. Oncol. 31, 1285–1292 (2013). · DOI · Paper page
  6. Geyer, H. L. et al. Distinct clustering of symptomatic burden among myeloproliferative neoplasm patients: retrospective assessment in 1470 patients. Blood 123, 3803–3810 (2014). · DOI
  7. Cleeland, C. S. & Williams, L. A. Symptom burden in hematologic malignancies. Blood 123, 3686–3687 (2014). · doi:10.1182/blood-2014-03-558981
  8. Rock, E. P. et al. Patient-reported outcomes supporting anticancer product approvals. J. Clin. Oncol. 25, 5094–5099 (2007). · doi:10.1200/jco.2007.11.3803
  9. Burris, H. A. et al. Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: a randomized trial. J. Clin. Oncol. 15, 2403–2413 (1997). · DOI · Paper page
  10. Bakitas, M. A. et al. Early versus delayed initiation of concurrent palliative oncology care: patient outcomes in the ENABLE III randomized controlled trial. J. Clin. Oncol. 33, 1438–1445 (2015). · DOI · Paper page
  11. Grudzen, C. R. et al. Emergency department-initiated palliative care in advanced cancer: a randomized clinical trial. JAMA Oncol. 2, 591–598 (2016). · DOI · Paper page
  12. Smith, T. J. et al. American Society of Clinical Oncology provisional clinical opinion: the integration of palliative care into standard oncology care. J. Clin. Oncol. 30, 880–887 (2012). · DOI · Paper page
  13. Dionne-Odom, J. N. et al. Benefits of early versus delayed palliative care to informal family caregivers of patients with advanced cancer: outcomes from the ENABLE III randomized controlled trial. J. Clin. Oncol. 33, 1446–1452 (2015). · DOI · Paper page
  14. Fayers, P. & Bottomley, A. Quality of life research within the EORTC — the EORTC QLQ-C30. Eur. J. Cancer 38 (Suppl. 4), 125–133 (2002). · DOI · Paper page
  15. Basch, E. et al. Development of the National Cancer Institute's patient-reported outcomes version of the common terminology criteria for adverse events (PRO-CTCAE). J. Natl. Cancer Inst. 106, dju244 (2014). · DOI · Paper page
  16. Basch, E. Patient-reported outcomes — harnessing patients' voices to improve clinical care. N. Engl. J. Med. 376, 105–108 (2017). · DOI · Paper page
  17. Sperti, E. & Di Maio, M. Outcomes research: integrating PROs into the clinic — overall survival benefit or not, it's worth the trouble. Nat. Rev. Clin. Oncol. 14, 529–530 (2017). · DOI
  18. Basch, E. et al. Patient online self-reporting of toxicity symptoms during chemotherapy. J. Clin. Oncol. 23, 3552–3561 (2005). · DOI · Paper page
  19. Abernethy, A. P. et al. Feasibility and acceptability to patients of a longitudinal system for evaluating cancer-related symptoms and quality of life: pilot study of an e/Tablet data-collection system in academic oncology. J. Pain Symptom Manage. 37, 1027–1038 (2009). · DOI
  20. Abernethy, A. P. et al. Validation of the Patient Care Monitor (Version 2.0): a review of system assessment instrument for cancer patients. J. Pain Symptom Manage. 40, 545–558 (2010). · DOI
  21. Bennett, A. V., Jensen, R. E. & Basch, E. Electronic patient-reported outcome systems in oncology clinical practice. CA Cancer J. Clin. 62, 337–347 (2012). · DOI · Paper page
  22. Snyder, C. F. et al. PatientViewpoint: a website for patient-reported outcomes assessment. Qual. Life Res. 18, 793–800 (2009). · DOI · Paper page
  23. Judson, T. J. et al. Feasibility of long-term patient self-reporting of toxicities from home via the Internet during routine chemotherapy. J. Clin. Oncol. 31, 2580–2585 (2013). · DOI · Paper page
  24. Wood, W. A. et al. Feasibility of frequent patient-reported outcome surveillance in patients undergoing hematopoietic cell transplantation. Biol. Blood Marrow Transplant. 19, 450–459 (2013). · DOI
  25. Abernethy, A. P. et al. Improving health care efficiency and quality using tablet personal computers to collect research-quality, patient-reported data. Health Serv. Res. 43, 1975–1991 (2008). · DOI · Paper page
  26. Lewis, G., Sharp, D., Bartholomew, J. & Pelosi, A. J. Computerized assessment of common mental disorders in primary care: effect on clinical outcome. Fam. Pract. 13, 120–126 (1996). · DOI · Paper page
  27. Drummond, H. E., Ghosh, S., Ferguson, A., Brackenridge, D. & Tiplady, B. Electronic quality of life questionnaires: a comparison of pen-based electronic questionnaires with conventional paper in a gastrointestinal study. Qual. Life Res. 4, 21–26 (1995). · DOI
  28. O'Connor, K. P., Hallam, R. S. & Hinchcliffe, R. Evaluation of a computer interview system for use with neuro-otology patients. Clin. Otolaryngol. Allied Sci. 14, 3–9 (1989). · DOI
  29. Fortner, B., Okon, T., Schwartzberg, L., Tauer, K. & Houts, A. C. The Cancer Care Monitor: psychometric content evaluation and pilot testing of a computer administered system for symptom screening and quality of life in adult cancer patients. J. Pain Symptom Manage. 26, 1077–1092 (2003). · DOI
  30. Muehlhausen, W. et al. Equivalence of electronic and paper administration of patient-reported outcome measures: a systematic review and meta-analysis of studies conducted between 2007 and 2013. Health Qual. Life Outcomes 13, 167 (2015). · DOI · Paper page
  31. Jensen, R. E. et al. Review of electronic patient-reported outcomes systems used in cancer clinical care. J. Oncol. Pract. 10, e215–e222 (2014). · DOI · Paper page
  32. Cirillo, M. et al. Clinician versus nurse symptom reporting using the National Cancer Institute-Common Terminology Criteria for Adverse Events during chemotherapy: results of a comparison based on patient's self-reported questionnaire. Ann. Oncol. 20, 1929–1935 (2009). · DOI
  33. Trotti, A. et al. CTCAE v3.0: development of a comprehensive grading system for the adverse effects of cancer treatment. Semin. Radiat. Oncol. 13, 176–181 (2003). · DOI · Paper page
  34. Atkinson, T. M. et al. The association between clinician-based common terminology criteria for adverse events (CTCAE) and patient-reported outcomes (PRO): a systematic review. Support Care Cancer 24, 3669–3676 (2016). · DOI · Paper page
  35. Basch, E., Rogak, L. J. & Dueck, A. C. Methods for implementing and reporting patient-reported outcome (PRO) measures of symptomatic adverse events in cancer clinical trials. Clin. Ther. 38, 821–830 (2016). · DOI · Paper page
  36. Jacobsen, P. B. et al. Screening for psychologic distress in ambulatory cancer patients. Cancer 103, 1494–1502 (2005). · DOI · Paper page
  37. Cleeland, C. S. et al. Assessing symptom distress in cancer patients: the M. D. Anderson Symptom Inventory. Cancer 89, 1634–1646 (2000). · DOI · Paper page
  38. Basch, E. et al. Long-term toxicity monitoring via electronic patient-reported outcomes in patients receiving chemotherapy. J. Clin. Oncol. 25, 5374–5380 (2007). · DOI · Paper page
  39. Wysham, N. et al. Integration of electronic patient-reported outcomes into routine cancer care: an analysis of factors affecting data completeness. JCO Clin. Cancer Informat. http://dx.doi.org/10.1200/CCI.16.00043 (2017). · DOI
  40. Di Maio, M., Basch, E., Bryce, J. & Perrone, F. Patient-reported outcomes in the evaluation of toxicity of anticancer treatments. Nat. Rev. Clin. Oncol. 13, 319–325 (2016). · DOI · Paper page
  41. LeBlanc, T. W. & Abernethy, A. P. Quality of life in higher resolution: the next generation of comparative effectiveness research in malignant hematology. Haematologica 98, 823–824 (2013). · DOI
  42. Pakhomov, S. V., Jacobsen, S. J., Chute, C. G. & Roger, V. L. Agreement between patient-reported symptoms and their documentation in the medical record. Am. J. Manag. Care 14, 530–539 (2008).
  43. Flynn, K. E. et al. Patient experiences with communication about sex during and after treatment for cancer. Psychooncology 21, 594–601 (2012). · DOI · Paper page
  44. Reese, J. B., Shelby, R. A., Keefe, F. J., Porter, L. S. & Abernethy, A. P. Sexual concerns in cancer patients: a comparison of GI and breast cancer patients. Support Care Cancer 18, 1179–1189 (2010). · DOI
  45. Dudgeon, D. et al. Cancer Care Ontario's experience with implementation of routine physical and psychological symptom distress screening. Psychooncology 21, 357–364 (2012). · DOI · Paper page
  46. Baba, K., Fransson, P. & Lindh, J. Use of a modified ESAS in cancer patients: a pilot study of patient and staff experiences. Int. J. Palliat. Nurs. 13, 610–616 (2007). · doi:10.12968/ijpn.2007.13.12.27890
  47. Rees, E., Hardy, J., Ling, J., Broadley, K. & A'Hern, R. The use of the Edmonton Symptom Assessment Scale (ESAS) within a palliative care unit in the UK. Palliat. Med. 12, 75–82 (1998). · DOI · Paper page
  48. Booth, C. M. & del Paggio, J. C. Approvals in 2016: questioning the clinical benefit of anticancer therapies. Nat. Rev. Clin. Oncol. 14, 135–136 (2017). · DOI
  49. Mooney, K. H. et al. Automated home monitoring and management of patient-reported symptoms during chemotherapy: results of the symptom care at home RCT. Cancer Med. 6, 537–546 (2017). · DOI · Paper page
  50. Reese, J. B., Shelby, R. A. & Abernethy, A. P. Sexual concerns in lung cancer patients: an examination of predictors and moderating effects of age and gender. Support Care Cancer 19, 161–165 (2011). · DOI
  51. Dupont, A. et al. Use of tablet personal computers for sensitive patient-reported information. J. Support Oncol. 7, 91–97 (2009).
  52. Suh, S. Y., LeBlanc, T. W., Shelby, R. A., Samsa, G. P. & Abernethy, A. P. Longitudinal patient-reported performance status assessment in the cancer clinic is feasible and prognostic. J. Oncol. Pract. 7, 374–381 (2011). · DOI
  53. Nilsson, S. et al. A randomized, dose-response, multicenter phase II study of radium-223 chloride for the palliation of painful bone metastases in patients with castration-resistant prostate cancer. Eur. J. Cancer 48, 678–686 (2012). · DOI · Paper page
  54. Quinten, C. et al. Baseline quality of life as a prognostic indicator of survival: a meta-analysis of individual patient data from EORTC clinical trials. Lancet Oncol. 10, 865–871 (2009). · DOI · Paper page
  55. Abernethy, A. P. et al. Rapid-learning system for cancer care. J. Clin. Oncol. 28, 4268–4274 (2010). · DOI · Paper page
  56. Etheredge, L. M. A rapid-learning health system. Health Aff. 26, w107–w118 (2007). · DOI · Paper page
  57. Olsen, L., Aisner, D. & McGinnis, J. M. (eds) The learning healthcare system: workshop summary (National Academies Press, 2007).
  58. Abernethy, A. P. et al. Electronic patient-reported data capture as a foundation of rapid learning cancer care. Med. Care 48, S32–S38 (2010). · DOI · Paper page
  59. Gershon, R. C., Rothrock, N., Hanrahan, R., Bass, M. & Cella, D. The use of PROMIS and assessment center to deliver patient-reported outcome measures in clinical research. J. Appl. Meas. 11, 304–314 (2010).
  60. Kristjanson, L. J. Validity and reliability testing of the FAMCARE Scale: measuring family satisfaction with advanced cancer care. Soc. Sci. Med. 36, 693–701 (1993). · DOI · Paper page
  61. Bruera, E., Kuehn, N., Miller, M. J., Selmser, P. & Macmillan, K. The Edmonton Symptom Assessment System (ESAS): a simple method for the assessment of palliative care patients. J. Palliat. Care 7, 6–9 (1991). · DOI · Paper page
  62. Portenoy, R. K. et al. The Memorial Symptom Assessment Scale: an instrument for the evaluation of symptom prevalence, characteristics and distress. Eur. J. Cancer 30A, 1326–1336 (1994). · DOI · Paper page
  63. Cleeland, C. S. & Ryan, K. M. Pain assessment: global use of the Brief Pain Inventory. Ann. Acad. Med. Singapore 23, 129–138 (1994).
  64. Revicki, D. A. et al. Development and psychometric analysis of the PROMIS pain behavior item bank. Pain 146, 158–169 (2009). · DOI · Paper page
  65. Jeffery, D. D. et al. Initial report of the cancer Patient-Reported Outcomes Measurement Information System (PROMIS) sexual function committee: review of sexual function measures and domains used in oncology. Cancer 115, 1142–1153 (2009). · DOI
  66. Pereira, J. et al. Population-based standardized symptom screening: Cancer Care Ontario's Edmonton Symptom Assessment System and performance status initiatives. J. Oncol. Pract. 10, 212–214 (2014). · DOI
  67. Nekolaichuk, C., Watanabe, S. & Beaumont, C. The Edmonton Symptom Assessment System: a 15-year retrospective review of validation studies (1991—2006). Palliat. Med. 22, 111–122 (2008). · DOI · Paper page
  68. Pereira, J. L. et al. Cancer care professionals' attitudes toward systematic standardized symptom assessment and the Edmonton Symptom Assessment System after large-scale population-based implementation in Ontario, Canada. J. Pain Symptom Manage. 51, 662–672 (2016). · DOI
  69. El-Jawahri, A. et al. Effect of inpatient palliative care on quality of life 2 weeks after hematopoietic stem cell transplantation: a randomized clinical trial. JAMA 316, 2094–2103 (2016). · DOI · Paper page
  70. El-Jawahri, A. et al. Effect of inpatient palliative care during hematopoietic stem-cell transplant on psychological distress 6 months after transplant: results of a randomized clinical trial. J. Clin. Oncol. http://dx.doi.org/10.1200/JCO.2017.73.2800 (2017). · DOI · Paper page
  71. Temel, J. S. et al. Effects of early integrated palliative care in patients with lung and gi cancer: a randomized clinical trial. J. Clin. Oncol. 35, 834–841 (2017). · DOI · Paper page
  72. LeBlanc, T. W., Roeland, E. J. & El-Jawahri, A. Early palliative care for patients with hematologic malignancies: is it really so difficult to achieve? Curr. Hematol. Malig. Rep. 12, 300–308 (2017). · DOI

Cited by

Metadata

Authors
LeBlanc, T. W., & Abernethy, A. P.
Venue
Nature Reviews Clinical Oncology
Published
2017-10-04
Volume
14
Issue
12
Pages
763-772
ISSN
  • 1759-4774 (ISSN-L)
  • 1759-4782
OpenAlex
W2762027870
Cited by
243
References
25
FWCI
2.06
Type
journal article
Language
en
Open access
closed
Licence
www.springer.com/tdm (tdm)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.